Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levobupivacaine caudal-epidural safety study in infants aged 3 to 6 months undergoing bladder exstrophy repair
2015-000393-34Phase 2Completed
- Sponsor
- Manchester University NHS Foundation Trust
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of levobupivacaine in bladder exstrophy and postoperative pain, sponsored by Manchester University NHS Foundation Trust. Primary endpoint: Primary safety endpoint. Started Apr 2015; status: completed.
02
Drugs
levobupivacaine
03
Conditions
bladder exstrophypostoperative pain
Beyond the preview
Go deeper on 2015-000393-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000393-34.